Sharon Elad
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Dentistry |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 683
Rochester NY 14642
|
|---|
|
|
|
-
Gibson RJ, Keefe DM, Lalla RV, Bateman E, Blijlevens N, Fijlstra M, King EE, Stringer AM, van der Velden WJ, Yazbeck R, Elad S, Bowen JM. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer. 2013 Jan; 21(1):313-26.
-
Elad S, Bowen J, Zadik Y, Lalla RV. Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process. Support Care Cancer. 2013 Jan; 21(1):309-12.
-
Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Jan; 21(1):357-64.
-
Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Jan; 21(1):333-41.
-
Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2013 Jan; 21(1):327-32.
-
Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Jan; 21(1):343-55.
-
Bowen JM, Elad S, Hutchins RD, Lalla RV. Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update. Support Care Cancer. 2013 Jan; 21(1):303-8.
-
Zadik Y, Abu-Tair J, Yarom N, Zaharia B, Elad S. The importance of a thorough medical and pharmacological history before dental implant placement. Aust Dent J. 2012 Sep; 57(3):388-92.
-
Alajbeg I, Falcão DP, Tran SD, Martín-Granizo R, Lafaurie GI, Matranga D, Pejda S, Vuletic L, Mantilla R, Leal SC, Bezerra AC, Ménard HA, Kimoto S, Pan S, Maniegas L, Krushinski CA, Melilli D, Campisi G, Paderni C, Mendoza GR, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, López Sánchez RM, Lassauzay C, Fromentin O, Beiski BZ, Strietzel FP, Konttinen YT, Wolff A, Zunt SL. Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jun; 113(6):773-81.
-
Mouth care protocol for oral mucositis. J Oncol Pharm Pract. 2012 Mar; 18(1):158.
-
Elad S, Epstein JB, Raber-Durlacher J, Donnelly P, Strahilevitz J. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial. J Oral Pathol Med. 2012 Mar; 41(3):229-34.
-
Elad S, Sherman Y, Palmon A, Vlodavsky I, Or R. Heparanase expression in periapical granulomas and radicular cysts. Odontology. 2013 Jan; 101(1):96-102.
-
Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, Mohrbacher R, Levitt M, Greinwald R, Shapira MY. Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide-An Open, Randomized, Multicenter Study. Biol Blood Marrow Transplant. 2012 Jan; 18(1):134-40.
-
Hautmann AH, Elad S, Lawitschka A, Greinix H, Bertz H, Halter J, Faraci M, Hofbauer LC, Lee S, Wolff D, Holler E. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Transpl Int. 2011 Sep; 24(9):867-79.
-
Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, Haddad R, Antin JH, Soiffer R, Treister N. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011 Jun; 46(6):884-91.
-
Volfin G, Yarom N, Elad S, Volpin G. [The use of antibiotic prophylaxis prior to dental procedures for the prevention of prosthetic joint infection]. Refuat Hapeh Vehashinayim. 2011 Apr; 28(2):35-45, 74.
-
Elad S, Binenfeld-Alon E, Zadik Y, Aharoni M, Findler M. Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study. Quintessence Int. 2011 Mar; 42(3):243-51.
-
Elad S, Epstein JB, von Bültzingslöwen I, Drucker S, Tzach R, Yarom N. Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents. Expert Opin Emerg Drugs. 2011 Mar; 16(1):183-202.
-
Strietzel FP, Lafaurie GI, Mendoza GR, Alajbeg I, Pejda S, Vuletic L, Mantilla R, Falcão DP, Leal SC, Bezerra AC, Tran SD, Ménard HA, Kimoto S, Pan S, Martín-Granizo RA, Lozano ML, Zunt SL, Krushinski CA, Melilli D, Campisi G, Paderni C, Dolce S, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, López Sánchez RM, Beiski BZ, Wolff A, Konttinen YT. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum. 2011 Jan; 63(1):180-90.
-
Elad S, Luboshitz-Shon N, Cohen T, Wainchwaig E, Shapira MY, Resnick IB, Radiano R, Lubart R, Or R. A randomized controlled trial of visible-light therapy for the prevention of oral mucositis. Oral Oncol. 2011 Feb; 47(2):125-30.
-
Elad S, Zadik Y, Zeevi I, Miyazaki A, de Figueiredo MA, Or R. Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation. 2010 Dec 15; 90(11):1243-4.
-
Elad S, Epstein JB, Yarom N, Drucker S, Tzach R, von Bültzingslöwen I. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors. Expert Opin Emerg Drugs. 2010 Dec; 15(4):713-26.
-
Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig. 2011 Apr; 15(2):127-39.
-
Zadik Y, Vainstein V, Heling I, Neuman T, Drucker S, Elad S. Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain. J Endod. 2010 Sep; 36(9):1588-92.
-
Elad S, Zadik Y, Kaufman E, Leker R, Finfter O, Findler M. A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug; 110(2):145-50.
-
Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant. 2010 Dec; 16(12):1611-28.
-
Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, Elting LS, Spijkervet FK, Brennan MT. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer. 2010 Aug; 18(8):993-1006.
-
Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010 Jun; 46(6):452-6.
-
Elad S, Czerninski R, Fischman S, Keshet N, Drucker S, Davidovich T, Goldschmidt N. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis. Amyloid. 2010 Mar; 17(1):27-31.
-
Yarom N, Fedele S, Lazarovici TS, Elad S. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg. 2010 Mar; 68(3):705.
-
Yarom N, Elad S, Madrid C, Migliorati CA. Osteonecrosis of the jaws induced by drugs other than bisphosphonates - a call to update terminology in light of new data. Oral Oncol. 2010 Jan; 46(1):e1.
-
Elad S, Zeevi I, Or R, Resnick IB, Dray L, Shapira MY. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). Biol Blood Marrow Transplant. 2010 Jan; 16(1):62-9.
-
Tsirigotis P, Dray L, Resnick IB, Ackerstein A, Gesundheit B, Elad S, Or R, Shapira MY. Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma. Ann Hematol. 2010 Mar; 89(3):263-72.
-
Elad S, Gomori MJ, Ben-Ami N, Friedlander-Barenboim S, Regev E, Lazarovici TS, Yarom N. Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig. 2010 Feb; 14(1):43-50.
-
Elad S. Antibiotic prophylaxis: a NICE fade-out. Quintessence Int. 2009 Apr; 40(4):269-70.
-
Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009 Apr; 67(4):850-5.
-
Shapira MY, Resnick IB, Dray L, Aker M, Stepensky P, Elad S, Gesundeheidt B, Samuel S, Or R. A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus. Cytotherapy. 2009; 11(1):61-7.
-
Tsirigotis PD, Resnick IB, Or R, Elad S, Zilberman I, Yoffe L, Levovic A, Miron S, Gesundheit B, Slavin S, Shapira MY. Post-hematopoietic stem cell transplantion immune-mediated cytopenias. Immunotherapy. 2009 Jan; 1(1):39-47.
-
Zadik Y, Findler M, Livne S, Levin L, Elad S. Dentists' knowledge and implementation of the 2007 American Heart Association guidelines for prevention of infective endocarditis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Dec; 106(6):e16-9.
-
Elad S, Levitt M, M Y S. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment]. Refuat Hapeh Vehashinayim. 2008 Nov; 25(4):19-27, 72.
-
Elad S, Shapira MY, McNeal S, Or R, Garfunkel AA, Hirschhorn A, Bitan M, Resnick I, Benjamin G, Barasch A. Oral effects of nonmyeloablative stem cell transplantation: a prospective observational study. Quintessence Int. 2008 Sep; 39(8):673-8.
-
Elad S, Findler M. Periodontal surgery for patients receiving anticoagulant therapy. Arch Intern Med. 2008 Aug 11; 168(15):1719.
-
Utsman RA, Epstein JB, Elad S. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jul; 106(1):e11-7.
-
Elad S, Admon D, Kedmi M, Naveh E, Benzki E, Ayalon S, Tuchband A, Lutan H, Kaufman E. The cardiovascular effect of local anesthesia with articaine plus 1:200,000 adrenalin versus lidocaine plus 1:100,000 adrenalin in medically compromised cardiac patients: a prospective, randomized, double blinded study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun; 105(6):725-30.
-
Yarom N, Elad S. Comment on Pazianas et al.: lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int. 2008 Jun; 19(6):849-50; author reply 851.
-
Elad S, Chackartchi T, Shapira L, Findler M. A critically severe gingival bleeding following non-surgical periodontal treatment in patients medicated with anti-platelet. J Clin Periodontol. 2008 Apr; 35(4):342-5.
-
Elad S, Yarom N, Khamaisi M. Re: implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Fugazzoto PA, Lightfoot WS, Jaffin R, Kumar A.(J Periodontol 2007; 78: 1664-1669). J Periodontol. 2008 Apr; 79(4):584-5, author reply 585-6.
-
Khamaisi M, Elad S. Re: Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst. 2008 Jan 16; 100(2):155; author reply 155-6.
-
Elad S, Meyerowitz C, Shapira MY, Glick M, Bitan M, Amir G. Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jan; 105(1):59-64.
-
Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein M, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc. 2007 Dec; 138(12):1555-62; quiz 1614.
-
Bitan M, Or R, Shapira MY, Resnick IB, Gesundheit B, Ackerstein A, Samuel S, Elad S, Slavin S. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia. Bone Marrow Transplant. 2008 Jan; 41(1):69-78.
-
Elad S, Findler M, Benoliel R. [Antibiotic prophylaxis for the prevention of infective endocarditis--new guidelines of the American Heart Association]. Refuat Hapeh Vehashinayim. 2007 Jul; 24(3):19-21, 54.
-
Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int. 2007 Oct; 18(10):1363-70.
-
Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in cancer: part I--mechanisms. J Dent Res. 2007 Jun; 86(6):491-505.
-
Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II--clinical perspectives and management. J Dent Res. 2007 Jun; 86(6):506-18.
-
Elad S, Thierer T, Bitan M, Shapira MY, Meyerowitz C. A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation. Oral Oncol. 2008 Jan; 44(1):37-42.
-
Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, Elad S. Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab. 2007 Mar; 92(3):1172-5.
-
Elad S, Yarom N, Hamed W, Ayalon S, Yahalom R, Regev E. Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma. Clin Lab Haematol. 2006 Dec; 28(6):393-8.
-
Elad S, Heisler S, Shalit M. Saliva secretion in patients with allergic rhinitis. Int Arch Allergy Immunol. 2006; 141(3):276-80.
-
Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A, Samuel S, Elad S, Slavin S. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant. 2006 Jul; 12(7):712-8.
-
Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer. 2006 Jun; 14(6):528-32.
-
Elad S, Wexler A, Garfunkel AA, Shapira MY, Bitan M, Or R. Oral candidiasis prevention in transplantation patients: a comparative study. Clin Transplant. 2006 May-Jun; 20(3):318-24.
-
Elad S, Ackerstein A, Bitan M, Shapira MY, Resnick I, Gesundheit B, Cohen Y, Diss O, Barak D, Dray L, Or R. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006 Apr; 37(8):757-62.
-
Bitan M, Or R, Shapira MY, Resnick IB, Ackerstein A, Samuel S, Elad S, Slavin S. Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent. Haematologica. 2005 Aug; 90(8):1089-95.
-
Bitan M, Shapira MY, Resnick IB, Zilberman I, Miron S, Samuel S, Ackerstein A, Elad S, Israel S, Amar A, Fibach E, Or R, Slavin S. Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells. Exp Hematol. 2005 Jun; 33(6):713-8.
-
Almog DM, Illig KA, Elad S, Romano PR, Carter LC. Supplementary role of panoramic radiographs in the medical surveillance of a patient at risk for stroke. Compend Contin Educ Dent. 2005 Jun; 26(6):369-72; quiz 373, 399.
-
Almog DM, Elad S, Shortell C. The role of panoramic radiographs in the medical surveillance of a patient at risk for stroke: case report. Gen Dent. 2004 Nov-Dec; 52(6):514-6.
-
Shapira MY, Resnick IB, Bitan M, Ackerstein A, Samuel S, Elad S, Miron S, Zilberman I, Slavin S, Or R. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant. 2004 Jul; 34(2):155-9.
-
Almog DM, Illig KA, Elad S, Ganddini MR. The supplementary role of panoramic radiographs in diagnosis and prevention of life-threatening systemic health condition. Case report. N Y State Dent J. 2004 May-Jun; 70(5):40-3.
-
Bitan M, Resnick IB, Or R, Rokach A, Laxer U, Ackerstein A, Elad S, Slavin S, Shapira MY. Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliterans. Am J Hematol. 2003 Nov; 74(3):182-6.
-
Elad S, Or R, Shapira MY, Haviv A, Galili D, Garfunkel AA, Bitan M, Kaufman E. CO2 laser in oral graft-versus-host disease: a pilot study. Bone Marrow Transplant. 2003 Nov; 32(10):1031-4.
-
Shapira MY, Or R, Resnick IB, Bitan M, Ackerstein A, Samuel S, Elad S, Zilberman I, Miron S, Slavin S. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant. 2003 Sep; 32(6):557-61.
-
Elad S, Garfunkel AA, Or R, Michaeli E, Shapira MY, Galili D. Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients. Support Care Cancer. 2003 Oct; 11(10):674-7.
-
Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl Int. 2003 Sep; 16(9):665-70.
-
Elad S, Or R, Garfunkel AA, Shapira MY. Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Mar; 95(3):308-11.
-
Elad S, Czerninski R, Eliay E. [Burning mouth syndrome]. Harefuah. 2002 Apr; 141(4):384-7, 407.
-
Kaufman E, Garfunkel A, Findler M, Elad S, Zusman SP, Malamed SF, Galili D. [Emergencies evolving from local anesthesia]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):13-8, 98.
-
Garfunkel A, Galili D, Findler M, Zusman SP, Malamed SF, Elad S, Kaufman E. [Chest pains in the dental environment]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):51-9, 101.
-
Findler M, Elad S, Garfunkel A, Zusman SP, Malamed SF, Galili D, Kaufman E. [Syncope in the dental environment]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):27-33, 99.
-
Kaufman E, Garfunkel A, Galili D, Zusman SP, Malamed SF, Findler M, Elad S. [Allergy-related emergencies]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):60-6, 102.
-
Kaufman E, Garfunkel A, Findler M, Malamed SF, Zusman SP, Elad S, Galili D. [The potential dangers of endocrinal disorders]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):67-78, 102.
-
Zusman SP, Garfunkel A, Galili D, Findler M, Malamed SF, Elad S, Kaufman E. [Legal and ethical considerations of emergencies in the dental office]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):88-91, 103.
-
Galili D, Garfunkel A, Elad S, Zusman SP, Malamed SF, Findler M, Kaufman E. [Respiratory distress]. Refuat Hapeh Vehashinayim. 2002 Jan; 19(1):34-46, 100.
-
Elad S, Garfunkel AA, Enk CD, Galili D, Or R. Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Oct; 88(4):444-50.
-
Elad S, Cohen G, Zylber-Katz E, Findler M, Galili D, Garfunkel AA, Or R. Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients. J Oral Pathol Med. 1999 Apr; 28(4):170-2.
-
Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant. 1998 Dec; 22(12):1179-83.
-
Cohen G, Elad S, Or R, Galili D, Garfunkel AA. The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: a preliminary study. Oral Dis. 1997 Dec; 3(4):243-6.
-
Elad S, Galili D, Garfunkel AA, Or R. Thalidomide-induced perioral neuropathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct; 84(4):362-4.
-
Or R, Nagler A, Elad S, Naparstek E, Schechter D. Noncardiogenic pulmonary congestion following bone marrow transplantation. Respiration. 1997; 64(2):170-2.
-
Or R, Elad S, Shpilberg O, Eldor A. Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients. Am J Hematol. 1996 Sep; 53(1):46-8.
-
Or R, Nagler A, Shpilberg O, Elad S, Naparstek E, Kapelushnik J, Cass Y, Gillis S, Chetrit A, Slavin S, Eldor A. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation. 1996 Apr 15; 61(7):1067-71.
-
Elad S, Or R. [Veno-occlusive disease of the liver]. Harefuah. 1993 Feb 15; 124(4):217-21.
|
Elad's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
